DSCC1 as a Novel Biomarker in Hepatocellular Carcinoma: Diagnostic Potential, Prognostic Impact, Correlation With Key Pathways, and Association With the Immune Landscape
Overall, this study suggests that DSCC1 may function as a valuable prognostic biomarker, an early diagnostic indicator, and a potential therapeutic target in LIHC, given its diverse involvement in tumor progression, drug responsiveness, immune regulation, and genomic instability.
Authors
- Shahid Ullah Khan (ORCID: https://orcid.org/0009-0005-0741-0779)
- Shad Man
- Abdul Jamil Khan (ORCID: https://orcid.org/0009-0008-6234-1704)
Institutions
- Inner Mongolia Agricultural University (CN)
- Inner Mongolia University (CN)
- Dubai Medical College (AE)
Publication Details
- Journal
- The Journal of Gene Medicine
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1002/jgm.70045
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00